Contineum Therapeutics, Inc. (NASDAQ:CTNM) IPO

Contineum Therapeutics, Inc.

IPO

Priced at US$16.00 a share on Apr 4, 2024.

Price
US$16.00 a share
Shares offered
6,875,000 shares of Class A common stock
Offering size
US$110 million
Underwriters' option
Up to 1,031,250 more shares
Underwriters
Goldman Sachs & Co. LLC, Morgan Stanley, Stifel, RBC Capital Markets · In the order on the cover
Shares delivered
On or about Apr 9, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceDec 13, 2023
Filed publiclyMar 15, 2024
Amended onceApr 1, 2024
Shares registered with an exchangeApr 2, 2024
Declared effective by the SECApr 4, 2024
Final prospectus, with the priceApr 8, 2024

From the cover of the final prospectus (424B4) filed Apr 8, 2024